Cysteine Conjugate Beta Lyase 2 (CCbL2)

[Edit]

RBM1; KAT3; Kyneurenine Aminotransferase III; Kynurenine Oxoglutarate Transaminase 3; Cysteine-S-conjugate beta-lyase 2; Kynurenine--glyoxylate transaminase

Cysteine Conjugate Beta Lyase 2 (CCbL2)
Kynurenic acid (KYNA), a metabolite of tryptophan, is a broad-spectrum antagonist of excitatory amino acid receptors, suggesting it may participate in normal brain function as a modulator of glutamatergic neurotransmission. The level of KYNA is altered in several neurodegenerative diseases. KAT3 is a kynurenine aminotransferase that forms KYNA by transamination of kynurenine. CCBL2 is an aminotransferase that transaminates kynurenine to form kynurenic acid. Kynurenic acid is a metabolite of tryptophan. Multiple alternatively spliced transcript variants that encode different proteins have been described for this gene. This gene shares 5' exon structure with the RNA binding motif protein, X-linked-like 1 locus on chromosome 1, but the coding sequences are non-overlapping.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPG442Hu01 Recombinant Cysteine Conjugate Beta Lyase 2 (CCbL2) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies n/a Monoclonal Antibody to Cysteine Conjugate Beta Lyase 2 (CCbL2) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Cysteine Conjugate Beta Lyase 2 (CCbL2) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Cysteine Conjugate Beta Lyase 2 (CCbL2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Cysteine Conjugate Beta Lyase 2 (CCbL2) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPG442Mu01 Recombinant Cysteine Conjugate Beta Lyase 2 (CCbL2) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies n/a Monoclonal Antibody to Cysteine Conjugate Beta Lyase 2 (CCbL2) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Cysteine Conjugate Beta Lyase 2 (CCbL2) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Cysteine Conjugate Beta Lyase 2 (CCbL2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Cysteine Conjugate Beta Lyase 2 (CCbL2) ELISA Kit Customized Service Offer

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPG442Ra01 Recombinant Cysteine Conjugate Beta Lyase 2 (CCbL2) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies n/a Monoclonal Antibody to Cysteine Conjugate Beta Lyase 2 (CCbL2) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Cysteine Conjugate Beta Lyase 2 (CCbL2) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Cysteine Conjugate Beta Lyase 2 (CCbL2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Cysteine Conjugate Beta Lyase 2 (CCbL2) ELISA Kit Customized Service Offer
  1. "Characterization of kynurenine aminotransferase III, a novel member of a phylogenetically conserved KAT family."Gene 365:111-118(2006) [PubMed] [Europe PMC] [Abstract]
  2. "The full-ORF clone resource of the German cDNA consortium."BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract]
  3. "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
  4. "The DNA sequence and biological annotation of human chromosome 1." Nature 441:315-321(2006) [PubMed] [Europe PMC] [Abstract]
  5. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  6. "Lysine acetylation targets protein complexes and co-regulates major cellular functions."Science 325:834-840(2009) [PubMed] [Europe PMC] [Abstract]
  7. "Initial characterization of the human central proteome."BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]
  8. "N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB."Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012) [PubMed] [Europe PMC] [Abstract]